compounding pharmacy tirzepatide lawsuit The @strivepharmacy response to the Eli Lilly lawsuits over compound #tirzepatide Compounders protest as FDA removes

Abril 2025

Transfer hydrogenation catalysis in cells as a new approach to anticancer drug design

What the future holds for GLP-1 access in Mexico The GLP-1 landscape is shifting rapidly, both in Mexico and globally

In November of 2025, however, the drug's manufacturer Novo Nordisk announced a more affordable option: uninsured patients (or those who have insurance that doesn't cover Wegovy) can access all dose strengths of Wegovy injections at a reduced cash price of $349 per month via Novo Nordisk's direct-to-consumer online pharmacy, NovoCare

Early trials for semaglutide pills have suggested that they may at least be as effective, if not more effective than, than Ozempic